Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Sethuraman Natarajan Create: Alert

All | News | Filings
Date FiledTypeDescription
07/12/2023 4 Sethuraman Natarajan (Chief Scientific Officer) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 3,026 shares @ $18.002, valued at $54.5k
Sold 14,852 shares @ $18.039, valued at $267.9k
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
04/17/2023 144 Form 144 - Report of proposed sale of securities:
09/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/01/2021 4 Sethuraman Natarajan (Chief Scientific Officer) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Granted 243,639 options to buy @ $20, valued at $4.9M
10/28/2021 3 Sethuraman Natarajan (Chief Scientific Officer) has filed a Form 3 on Entrada Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy